/Companies

Xeltis

9 known investors

Find your way into Xeltis

Sign up to find every way you can get introduced to Xeltis

  • Your email: who you already know at Xeltis, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Xeltis team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.

Founders & leadership

ESEliane Schutte
Eliane SchutteChief Executive Officer

Investors · 9

Also in the syndicate · 3

DaVitaEuropean Innovation CouncilHorizon 3 Healthcarelead

In the news

Frequently asked questions

What does Xeltis do?
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology. The company targets patients requiring hemodialysis vascular access or cardiovascular replacements.
Who are Xeltis's investors?
Xeltis's investors include Kurma Partners, VI Partners, Ysios Capital, Amadeus Capital Partners, EQT Life Sciences, Invest-NL.